A Study to Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World Setting
Clinical trial NCT03448445 · COMPLETED
Trial details
- NCT number
- NCT03448445
- Sponsor
- Eisai Korea Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-06-22
- Primary completion
- 2021-08-10
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.